List view / Grid view
The African Vaccine Acquisition Trust (AVAT) has entered into an…
The African Vaccine Acquisition Trust (AVAT) has entered into an advanced purchase agreement for 220 million doses of Janssen COVID-19 Vaccine.
Following the selection of a COVID-19 vaccine lead, Johnson &…
Following the selection of a COVID-19 vaccine lead, Johnson & Johnson (J&J) aims to begin clinical trials in humans later this year while also scaling up its manufacturing facilities.
500,000 regimens of Janssen's investigational Ebola vaccine are to be…
500,000 regimens of Janssen's investigational Ebola vaccine are to be donated to support the Ebola outbreak response in the Democratic Republic of the Congo.
As part of EPR’s Women in Pharma series, Catherine Owen,…
As part of EPR’s Women in Pharma series, Catherine Owen, President of Infectious Disease and Vaccines at Johnson & Johnson, talks to Science Editor Dr Zara Kassam about keeping up with the competition, innovation and grasping the breadth of business...
Johnson & Johnson announced that its Board of Directors has…
23 June 2014 | By Johnson & Johnson
Johnson & Johnson announced that its Board of Directors has appointed D. Scott Davis, Chief Executive Officer and Chairman of United Parcel Service, Inc. as a Director of Johnson & Johnson...
Bill Weldon to step down after 41-year career at Johnson…
30 November 2012 | By Johnson & Johnson
Bill Weldon to step down after 41-year career at Johnson & Johnson...
